Guest guest Posted May 4, 2012 Report Share Posted May 4, 2012 Len and ,The ClearBlue monitor used by and the Marquette method detects an E3G above baseline, and gives a variable amount of high days before the peak (see 's paper "Variability in the hormonally estimated fertile phase of the menstrual cycle." Fertil Steril 2008, p. 1234). Because women have different baseline E3G levels, the amount of days of "High" for each woman on the monitor could be different. ClearBlue will ask for tests every day from Day 6 to Day 25 or so.Persona uses a proprietary algorithm as Len was alluding to which is likely something similar to LH-5 to LH+3 based on the previous 6 cycles. The monitor asks for a test on Day 6, and then for 7 other tests in the cycle starting on Day 8 or later based on previous cycle parameters. Because it does not ask for daily tests, it cannot be used in a customized way like has proposed for the Marquette breastfeeding protocol.Certainly having accurate data with timed collections is helpful, but of course wider availability of Brown's monitor via Len's work is needed before we can see it implemented. Hopefully a future PDG test could be (A) home-based, ( practical (without requiring sending to a lab), © have high specificity for ovulation. This would be an excellent adjunct to all NFP methods. Bouchard, MDFamily Medicine ResidentUniversity of Calgary On 2012-05-02, at 7:52 PM, Len Blackwell wrote: Dear , Thank you for your comments. Depending on your interest there are a number of articles you could read. Also some of the material Fehring and his team have published. The Brown Monitor differs from the Persona Monitors in that we use timed urine samples and measure both E1G and PdG. The first rise in E1G in a prospective sense is the marker for the beginning of the fertile window and the rise in PdG to exceed a thrreshold excretion rate to mark the end of the fertile window. See our 1992 and 1998 papers). The Persona device (and is more of an expert on this than I) is essentially a sophisticated calendar device. It works on the principle that if we knew when the LH peak was going to occur then we could define the fertile window as LH-5 to LH + 4 (I think). By monitoring for 6 cycles the range of LH peak days is determined and the algorithm constantly updates this so that the beginning of testing is the earliest LH peak day - 5. E1G is measured as well and if this is elevated to lie within one of two bands then fertility is signalled as having already started and obviously the LH peak day was actually earlier than predicted. The end of fertility is predicted from the LH peak day and not definitively determined. The Persona system uses early morning urine samples on the basis that the urine volume is more constant overnight. However, the urine volume can vary 10 fold from day to day.One of the barriers to widespread use of the Monitor was the perception that collecting timed urine samples is too difficult. However, the quality of the data is vastly improved by this correction for urine volume and it is only because we do this that we can measure the first rise in E1G above baseline levels. I hope this helps and am ready to be corrected by ! Regards, Len At 12:40 a.m. 3/05/2012, rbamer2@... wrote: Dear Len, thank you for your gracious reply. As someone who made it through med school and residency within the last 15 years and never heard a peep about NFP or the ability for women to monitor their cervical mucus, BBTs or perform urinary hormonal testing, I for one am thankful for you helping to disseminate Dr Browns findings, and for all the others in this group who have made such great contributions to the field as well. I have read Types of ovarian activity in women and their significance: the continuum and also A Study of Returning Fertility After Childbirth and During Lactation by Measurement of Urinary Estrogen and Pregnanediol Excretion and Cervical Mucus Production. Are there any other articles which you feel we should read? How does the Brown Monitor differ from the Clearblue or Persona monitors? If we want to convince medical professionals to learn about and offer NFP in their practices, it would be good for all of us to study the hormonal changes which create the readily observable fertile signs. This science, if further developed and made readily understandable to physicians and NFP Instructors alike, would unite all of the various NFP methods. One could still teach most people, i.e., a variant of the ovulation method, and it would suffice. But as the situation changes for the woman (the continuum) or for the "forgotten women of NFP" there would be other options. Of course, I realize that all of our methods have attempted to adapt our rules for patients who have special circumstances and the efficacy of these adaptations need to be further studied. I would look forward to a conference where your work would be summarized or reviewed again for those of us who are just beginning this journey. Blessings to you and your work, Dr Peck, MD, CCD, Marquette NFP Instructor Sent via BlackBerry by AT & T From: Len Blackwell <L.F.Blackwell@...> Sender: Date: Wed, 02 May 2012 17:48:08 +1200 < > Reply Subject: Fwd: Re: NFP from pulpit..help with wording? --- Re: NFP from pulpit..help with wording? Yes in principle. With PdG a single value will give you the answer but with the BBT you must have daily measurements and then if the BBT increase following a mucus patch was small and lasted a single day it might be difficult to interpret. However, I leave the BBT experts to discuss this. Len Blackwell On 1/05/2012 2:03 a.m., Kippley wrote: Wouldn't the elevation or non-elevation of the basal temperature after a mucus patch accomplish the same thing? Kippley <PdG.pdf><triggs.pdf> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 4, 2012 Report Share Posted May 4, 2012 I have heard an Indian company holds a patent on a urinary PDG test.M Wouldn't the elevation or non-elevation of the basal temperature after a mucus patch accomplish the same thing? Kippley <PdG.pdf><triggs.pdf> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 4, 2012 Report Share Posted May 4, 2012 Do you have any more information? Len On 5/05/2012 1:41 p.m., Davenport wrote:  I have heard an Indian company holds a patent on a urinary PDG test. M  Wouldn't the elevation or non-elevation of the basal temperature after a mucus patch accomplish the same thing? Kippley <PdG.pdf><triggs.pdf> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.